Ian Eliason

Naturally, entrepreneurial Ian has been with Zoic since its inception in 2014, when it was little more than a concept on the back of a napkin. He helped develop the investment strategy, build the deal flow network, and constructed the operational infrastructure necessary to launch then manage institutional level capital. Within his role at Zoic Ian has evaluated over 1,000 life sciences companies, and he plays a key role in the firm’s investment decisions including deal selection and structuring. If you want to learn more about Zoic, the types of companies we invest in, or if you’d like to exchange good reads and travel ideas, send me an email: ian@zoiccapital.com